Success Metrics

Completion Rate
0%(0/1)
Active Trials
0(0%)
Terminated
1(25%)

Phase Distribution

Ph phase_2
2
50%
Ph not_applicable
1
25%

Phase Distribution

0

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution3 total trials
Phase 2Efficacy & side effects
2(66.7%)
N/ANon-phased studies
1(33.3%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Terminated(1)
Other(2)

Detailed Status

unknown2
Not yet recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
0.0%
Most Advanced
Phase 2

Trials by Phase

Phase 22 (66.7%)
N/A1 (33.3%)

Trials by Status

unknown250%
not_yet_recruiting125%
terminated125%

Recent Activity

0 active trials
Showing 4 of 4
not_yet_recruitingphase_2

The CATSINDO Trial - Clinical and Translational Study in Newly Diagnosed Osteosarcoma

NCT07560826
unknown

Retrospective Registry Study of Patients With Cancer Treated With High-dose Methotrexate

NCT05899751
unknownnot_applicable

Childhood Acute Lymphoblastic Leukemia Treatment Protocol Moscow-Berlin 2008

NCT01953770
terminatedphase_2

Re-Induction Therapy for Relapsed Pediatric T-Cell Acute Lymphoblastic Leukemia or Lymphoma

NCT02518750

Clinical Trials (4)

Showing 4 of 4 trials
NCT07560826Phase 2

The CATSINDO Trial - Clinical and Translational Study in Newly Diagnosed Osteosarcoma

Not Yet Recruiting
NCT05899751

Retrospective Registry Study of Patients With Cancer Treated With High-dose Methotrexate

Unknown
NCT01953770Not Applicable

Childhood Acute Lymphoblastic Leukemia Treatment Protocol Moscow-Berlin 2008

Unknown
NCT02518750Phase 2

Re-Induction Therapy for Relapsed Pediatric T-Cell Acute Lymphoblastic Leukemia or Lymphoma

Terminated

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4